关注
Tina  Xiong
Tina Xiong
在 merck.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Targeted DNA methylation in human cells using engineered dCas9-methyltransferases
T Xiong, GE Meister, RE Workman, NC Kato, MJ Spellberg, F Turker, ...
Scientific reports 7 (1), 6732, 2017
942017
Structure-guided discovery of aminoquinazolines as brain-penetrant and selective LRRK2 inhibitors
MH Keylor, A Gulati, SD Kattar, RE Johnson, RW Chau, KA Margrey, ...
Journal of medicinal chemistry 65 (1), 838-856, 2021
252021
Stability of a guest protein depends on stability of a host protein in insertional fusion
B Pierre, T Xiong, L Hayles, VR Guntaka, JR Kim
Biotechnology and bioengineering 108 (5), 1011-1020, 2011
242011
Molecular determinants for protein stabilization by insertional fusion to a thermophilic host protein
B Pierre, JW Labonte, T Xiong, E Aoraha, A Williams, V Shah, E Chau, ...
ChemBioChem 16 (16), 2392-2402, 2015
122015
Protein engineering strategies for improving the selective methylation of target CpG sites by a dCas9-directed cytosine methyltransferase in bacteria
T Xiong, D Rohm, RE Workman, L Roundtree, CD Novina, W Timp, ...
PLoS One 13 (12), e0209408, 2018
112018
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease
DA Candito, V Simov, A Gulati, S Kattar, RW Chau, BT Lapointe, ...
Journal of Medicinal Chemistry 65 (24), 16801-16817, 2022
102022
The interplay between effector binding and allostery in an engineered protein switch
JH Choi, T Xiong, M Ostermeier
Protein Science 25 (9), 1605-1616, 2016
72016
Protein engineering strategies to improve efficiency in biomass degradation
LF Ribeiro, T Xiong, P Hauk, LF Ribeiro
Mycology: Current and Future Developments 1, 202-221, 2016
62016
Protein-surfactant-polysaccharide nanoparticles increase the catalytic activity of an engineered β-lactamase maltose-activated switch enzyme
JP Fuenzalida, T Xiong, BM Moerschbacher, M Ostermeier, ...
bioRxiv, 746560, 2019
42019
Discovery of MK-1468: a potent, kinome-selective, brain-penetrant amidoisoquinoline LRRK2 inhibitor for the potential treatment of Parkinson’s disease
SD Kattar, A Gulati, KA Margrey, MH Keylor, M Ardolino, X Yan, ...
Journal of Medicinal Chemistry 66 (21), 14912-14927, 2023
32023
Systems and methods for genome modification and regulation
C Novina, G Meister, M Ostermeier, T Xiong
US Patent App. 15/539,256, 2017
22017
Targeted Cytosine Methylation using dCas9-methyltransferases
T Xiong
Johns Hopkins University, 2017
2017
Fusion of both methyltransferase fragments to different DNA-binding domains
T Xiong, C Novina, M Ostermeier
Targeted Cytosine Methylation using dCas9-methyltransferases, 112, 2017
2017
Protein engineering strategies for improving the selective methylation of targeted CpG sites using a dCas9-directed cytosine methyltransferase
T Xiong, RE Workman, D Rohm, L Roundtree, C Novina, W Timp, ...
Targeted Cytosine Methylation using dCas9-methyltransferases, 81, 2017
2017
Supplemental Information Targeted DNA methylation in human cells using engineered dCas9-methyltransferases
T Xiong, GE Meister, RE Workman, NC Kato, MJ Spellberg, F Turker, ...
系统目前无法执行此操作,请稍后再试。
文章 1–15